RA
OSIR

Royce & Associates’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Royce & Associates’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-825
Closed -$16K – 1240
2019
Q1 		$16K Buy
+825
New +$13.4K ﹤0.01% 1134

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Royce & Associates's OSIR Position: Q2 2019 in Review

Royce & Associates sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 825 shares — an estimated $16K sold.

Royce & Associates first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $16K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Royce & Associates reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Royce & Associates sold 825 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $16K.
  • Royce & Associates first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Royce & Associates's Osiris Therapeutics, Inc. Common Stock position peaked at $16K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Royce & Associates's 13F filing for Q2 2019, filed 12 Aug 2019.